Search results
Zacks Research Analysts Reduce Earnings Estimates for Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 5 days agoEli Lilly and Company (NYSE:LLY – Free Report) – Research analysts at Zacks Research decreased their Q1 2025 EPS estimates for Eli < ...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 17 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Eli Lilly to acquire manufacturing facility from Nexus Pharma
Reuters· 3 days ago, opens new tab said on Monday that it will acquire a manufacturing facility from Nexus...
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With...
Motley Fool via Yahoo Finance· 5 days agoEli Lilly and Novo Nordisk are two of the biggest names in healthcare thanks in large part to some...
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 2 days agoThe most recent trading session ended with Eli Lilly (LLY) standing at $731.33, reflecting a +0.69%...
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
Zacks via Yahoo Finance· 7 days agoData from Eli Lilly's (LLY) SURMOUNT-OSA studies show that treatment with tirzepatide results in a...
Zepbound shortage update: FDA issues 'limited availability' warning. When might it end?
Fast Company Magazine· 7 days agoIn response to a surge in demand, Zepbound, the weight loss drug manufactured by Eli Lilly, is...
Eli Lilly buying Nexus Pharmaceuticals facility
Crain s Chicago Business· 2 days agoLilly hopes to begin production at the newly built facility at the end of 2025, the release said. “The acquisition of this state-of-the-art facility underscores our unwavering ...
Eli Lilly subsidiary ends lucrative collaboration with Durham biotech - Triangle Business Journal
The Business Journals· 7 days agoA subsidiary of Eli Lilly and Co. has ended a multimillion-dollar collaboration with a Durham gene...
Lilly’s weight-loss drug reduces sleep apnea severity in late-stage trials
New York Post· 6 days agoApril 17 (Reuters) – Eli Lilly (LLY.N), said on Wednesday its weight-loss drug helped reduce...
